Omnicell Operating Margin 2010-2025 | OMCL

Current and historical operating margin for Omnicell (OMCL) over the last 10 years. The current operating profit margin for Omnicell as of March 31, 2025 is 5.00%.
Omnicell Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $1.14B $0.01B 0.88%
2024-12-31 $1.11B 0 0.00%
2024-09-30 $1.06B $-0.04B -3.29%
2024-06-30 $1.08B $-0.04B -3.52%
2024-03-31 $1.10B $-0.03B -2.99%
2023-12-31 $1.15B $-0.03B -2.96%
2023-09-30 $1.19B $-0.05B -4.13%
2023-06-30 $1.24B $-0.04B -2.83%
2023-03-31 $1.27B $-0.03B -2.44%
2022-12-31 $1.30B $0.00B -0.23%
2022-09-30 $1.31B $0.05B 3.59%
2022-06-30 $1.26B $0.06B 4.61%
2022-03-31 $1.20B $0.08B 6.26%
2021-12-31 $1.13B $0.09B 7.95%
2021-09-30 $1.07B $0.10B 9.16%
2021-06-30 $0.99B $0.08B 8.00%
2021-03-31 $0.92B $0.04B 4.70%
2020-12-31 $0.89B $0.04B 3.92%
2020-09-30 $0.89B $0.04B 4.15%
2020-06-30 $0.91B $0.05B 5.73%
2020-03-31 $0.92B $0.08B 8.44%
2019-12-31 $0.90B $0.08B 8.81%
2019-09-30 $0.86B $0.08B 8.83%
2019-06-30 $0.84B $0.07B 8.13%
2019-03-31 $0.81B $0.06B 6.93%
2018-12-31 $0.79B $0.04B 5.58%
2018-09-30 $0.77B $0.04B 5.31%
2018-06-30 $0.76B $0.04B 4.77%
2018-03-31 $0.75B $0.03B 3.75%
2017-12-31 $0.71B $0.01B 1.40%
2017-09-30 $0.69B $0.01B 1.30%
2017-06-30 $0.68B $0.00B 0.29%
2017-03-31 $0.67B $0.00B 0.45%
2016-12-31 $0.70B $0.02B 3.16%
2016-09-30 $0.65B $0.02B 2.92%
2016-06-30 $0.60B $0.03B 4.67%
2016-03-31 $0.54B $0.04B 7.42%
2015-12-31 $0.48B $0.05B 9.92%
2015-09-30 $0.48B $0.05B 10.29%
2015-06-30 $0.46B $0.05B 10.56%
2015-03-31 $0.46B $0.05B 10.96%
2014-12-31 $0.44B $0.05B 11.31%
2014-09-30 $0.43B $0.05B 11.27%
2014-06-30 $0.41B $0.05B 11.06%
2014-03-31 $0.40B $0.04B 10.35%
2013-12-31 $0.38B $0.04B 9.19%
2013-09-30 $0.37B $0.03B 9.32%
2013-06-30 $0.36B $0.03B 9.58%
2013-03-31 $0.34B $0.03B 8.04%
2012-12-31 $0.31B $0.03B 8.63%
2012-09-30 $0.29B $0.02B 8.04%
2012-06-30 $0.27B $0.02B 6.39%
2012-03-31 $0.25B $0.02B 7.54%
2011-12-31 $0.25B $0.02B 6.53%
2011-09-30 $0.24B $0.01B 5.02%
2011-06-30 $0.23B $0.01B 4.33%
2011-03-31 $0.23B $0.01B 4.00%
2010-12-31 $0.22B $0.01B 4.50%
2010-09-30 $0.22B $0.01B 4.09%
2010-06-30 $0.22B $0.01B 3.21%
2010-03-31 $0.22B $0.01B 2.31%
2009-12-31 $0.21B 0 0.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.324B $1.112B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.989B 58.51
Hims & Hers Health (HIMS) United States $13.669B 142.02
Tempus AI (TEM) United States $11.962B 0.00
IRhythm Technologies (IRTC) United States $4.646B 0.00
Inspire Medical Systems (INSP) United States $3.825B 59.77
Hinge Health (HNGE) United States $3.100B 0.00
Privia Health (PRVA) United States $2.659B 181.75
Enovis (ENOV) United States $1.751B 9.76
Schrodinger (SDGR) United States $1.545B 0.00
Phreesia (PHR) United States $1.527B 0.00
Clover Health Investments (CLOV) United States $1.511B 0.00
Azenta (AZTA) United States $1.371B 63.70
10x Genomics (TXG) United States $1.338B 0.00
Claritev (CTEV) United States $0.663B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.534B 0.00
Veradigm (MDRX) United States $0.482B 0.00
Talkspace (TALK) United States $0.463B 138.50
Standard BioTools (LAB) United States $0.414B 0.00
Outset Medical (OM) United States $0.347B 0.00
TruBridge (TBRG) United States $0.346B 766.67
Nyxoah SA (NYXH) Belgium $0.263B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.150B 0.00
EUDA Health Holdings (EUDA) Singapore $0.139B 0.00
Pulmonx (LUNG) United States $0.111B 0.00
CareCloud (CCLD) United States $0.107B 4.06
American Well (AMWL) United States $0.106B 0.00
MDxHealth SA (MDXH) Belgium $0.096B 0.00
111 (YI) China $0.068B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.046B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.031B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00